Abstract
Background
Frailty has become a high-priority issue in cardiovascular medicine because of the aging of cardiovascular patients. Simple and reproducible tools to assess frailty in elderly patients are clearly on demand. Their application may help physicians in the selection of invasive and medical treatments and in the timing and modality of the follow-up. The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program is designed with the aim to validate the use of the short physical performance battery (SPPB) as prognostic tools in patients admitted to hospital for acute coronary syndrome (ACS).
Methods
The FRASER program is a multicenter prospective study involving 4 Italian cardiology units. The FRASER program enrolls only patients aged ≥70 years. The core of the FRASER program includes patients admitted to hospital for ACS. The aims are (1) to describe SPPB distribution before hospital discharge and (2) to investigate the prognostic role of SPPB score. The primary outcome is a composite of 1-year all-cause mortality and hospital readmission for any cause. Ancillary analyses will be focused on different study populations (patients hospitalized for arrhythmias or acute heart failure or symptomatic severe aortic stenosis) and on different tools to assess frailty (multidimensional prognostic index, clinical frailty score, grip strength).
Discussion
The FRASER program will fill critical gaps in the knowledge regarding the link between frailty, cardiovascular disease, interventional procedures and outcome and will help physicians in the generation of a more personalized risk assessment and in the identification of potential targets for interventions.
Similar content being viewed by others
References
Sabetta T, Ricciardi W (2016) Health status of the Italian people: gender inequalities. Ann Ist Super Sanità 52:151–153
http://www.who.int/gho/mortality_burden_disease/life_tables/situation_trends_text/en/ Last seen 19 July 2016
Forman DE, Rich MW, Alexander KP et al (2011) Cardiac care for older adults: time for a new paradigm. JACC 57:1801–1810
Bergman H, Ferrucci L, Guralnik J et al (2007) Frailty: an emerging research and clinical paradigm—issues and controversies. J Gerontol A Biol Sci Med Sci 62:731–737
Fried LP, Tangen CM, Walston J et al (2001) Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156
Singh M, Stewart R, White H (2014) Importance of frailty in patients with cardiovascular disease. Eur Heart J 35:1726–1731
Sergi G, Veronese N, Fontana L et al (2015) Pre-Frailty and risk of cardiovascular disease in elderly men and women. JACC 65:10
Gambassi G, Cesari M, Tosato M et al (2013) In 6 minuti al cuore della fragilità: il test del cammino in cardiologia geriatrica. G Ital Cardiol 14(3 Suppl. 1):19S–25S
Chen PF, Wang DN, Chen K et al (2015) Outcomes of percutaneous coronary intervention in patients ≥75 years: one-center study in a Chinese patient group. J Geriatr Cardiol 12:626–633
Reeves GR, Whellan DJ, Patel MJ et al (2016) Comparison of frequency of frailty and severely impaired physical function in patients ≥60 years hospitalized with acute decompensated heart failure versus chronic stable heart failure with reduced and preserved left ventricular ejection fraction. Am J Cardiol 117:1953–1958
Windecker S, Kolh P, Alfonso F et al (2014) 2014 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 35:2541–2619
Guralnik J, Simonsick E, Ferrucci L et al (1994) A SPPB assessing lower extremity function: association with self reported disability and prediction of mortality and nursing home admission. J Gerontol Med Sci 42:85–94
Guralnik JM, Ferrucci L, Simonsick EM et al (1995) Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 332:556–561
Volpato S, Cavalieri M, Sioulis F et al (2011) Predictive value of the short physical performance battery following hospitalization in older patients. J Gerontol A Biol Sci Med Sci 66:89–96
Biscaglia S, Campo G, Pavasini R et al (2016) Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry. Platelets 27:484–487
Campo G, Pavasini R, Malagù M et al (2015) Relationship between troponin elevation, cardiovascular history and adverse events in patients with acute exacerbation of COPD. COPD 12:560–567
Tumscitz C, Pirani L, Tebaldi M et al (2014) Seven french radial artery access for PCI: a prospective single-center experience. Int J Cardiol 176:1074–1075
Mehran R, Rao SV, Bhatt DL et al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123:2736–2747
Cutlip DE, Windecker S, Mehran R et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351
Roberts HC, Denison HJ, Martin HJ et al (2011) A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardized approach. Age Ageing 40:423–429
Pilotto A, Ferrucci L, Franceschi M et al (2008) Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 11:151–161
Volpato S, Bazzano S, Fontana A et al (2015) Multidimensional prognostic index predicts mortality and length of stay during hospitalization in the older patients: a multicenter prospective study. J Gerontol A Biol Sci Med Sci 70:325–331
Rockwood K, Song X, MacKnight C et al (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173:489–495
Campo G, Morciano G, Pavasini R et al (2016) Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: preliminary findings. Int J Cardiol 9:993–997
Campo G, Valgimigli M, Ferraresi P et al (2006) Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arterioscler Thromb Vasc Biol 26:2800–2806
Campo G, Ferraresi P, Marchesini J et al (2011) Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention. J Thromb Haemost 9:2106–2108
Campo G, Marchesini J, Bristot L et al (2012) The in vitro effects of verbascoside on human platelet aggregation. J Thromb Thrombolysis 34:318–325
Valgimigli M, Tebaldi M, Campo G et al (2012) Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. JACC Cardiovasc Interv 5:268–277
Campo G, Pavasini R, Biscaglia S et al (2015) Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study. Pharmacol Res 97:1–6
Garg S, Sarno G, Girasis C et al (2011) A patient-level pooled analysis assessing the impact of the SYNTAX score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv 4:645–653
Garg S, Sarno G, Serruys PW et al (2011) Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY and MULTISTRATEGY trials. JACC Cardiovasc Interv 4:66–75
Kobayashi Y, Nam CW, Tonino PA et al (2016) the prognostic value of residual coronary stenoses after functionally complete revascularization. J Am Coll Cardiol 67:1701–1711
Purser JL, Weinberger M, Cohen HJ et al (2005) Walking speed predicts health status and hospital costs for frail elderly male veterans. J Rehabil Res Dev 42:535–546
Quadri P, Tettamanti M, Bernasconi S et al (2005) Lower limb function as predictor of falls and loss of mobility with social repercussions one year after discharge among elderly inpatients. Aging Clin Exp Res 17:82–89
Atkinson HH, Rosano C, Simonsick EM et al (2007) Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 62:844–850
Forrest KYZ, Zmuda JM, Cauley JA (2006) Correlates of decline in lower extremity performance in older women: a 10-year follow-up study. J Gerontol A Biol Sci Med Sci 61:1194–1200
Volpato S, Ble A, Metter EJ et al (2008) High-density lipoprotein cholesterol and objective measures of lower extremity performance in older nondisabled persons: the InChianti study. J Am Geriatr Soc 56:621–629
Volpato S, Leveille SG, Corti MC et al (2001) The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc 49:1142–1147
Huffman JC, Beale EE, Celano CM et al (2016) Effects of optimism and gratitude on physical activity, biomarkers, and readmissions after an acute coronary syndrome: the gratitude research in acute coronary events study. Circ Cardiovasc Qual Outcomes 9:55–63
Turkstra E, Hawkes AL, Oldenburg B et al (2013) Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart). BMC Cardiovasc Disord 13:33
Pahor M, Blair SN, Espeland M et al (2006) Effects of a physical activity intervention on measures of physical performance: results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci 61:1157–1165
Campo G, Saia F, Guastaroba P et al (2011) Prognostic impact of hospital readmissions after primary percutaneous coronary intervention. Arch Intern Med 171:1948–1949
Ferreiro JL, Angiolillo DJ (2012) New directions in antiplatelet therapy. Circ Cardiovasc Interv 5:433–445
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no relationships that could be construed as a conflict of interest.
Funding/support
The study was an investigator driven clinical trial conducted by the University of Ferrara.
Ethical approval
All procedures were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethics committee of the four participating institutions approved the protocol, and enrolled patients gave written informed consent before inclusion.
Statement of human and animal rights
This study was approved by the Ethical Review Committee of our hospital.
Informed consent
All participants will sign the consent at the time of the enrollment.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Campo, G., Pavasini, R., Maietti, E. et al. The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study. Aging Clin Exp Res 29, 895–903 (2017). https://doi.org/10.1007/s40520-016-0662-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-016-0662-y